| Target Price | $65.69 |
| Price | $40.79 |
| Potential |
61.04%
register free of charge
|
| Number of Estimates | 9 |
|
9 Analysts have issued a price target Harrow Health, Inc. 2026 .
The average Harrow Health, Inc. target price is $65.69.
This is
61.04%
register free of charge
$79.80
95.64%
register free of charge
$63.63
55.99%
register free of charge
|
|
| A rating was issued by 14 analysts: 13 Analysts recommend Harrow Health, Inc. to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Harrow Health, Inc. stock has an average upside potential 2026 of
61.04%
register free of charge
|
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 199.61 | 287.28 |
| 53.32% | 43.92% | |
| EBITDA Margin | 11.38% | 25.62% |
| 19.26% | 125.19% | |
| Net Margin | -8.76% | 5.47% |
| 53.29% | 162.46% |
10 Analysts have issued a sales forecast Harrow Health, Inc. 2025 . The average Harrow Health, Inc. sales estimate is
This results in the following potential growth metrics:
7 Analysts have issued an Harrow Health, Inc. EBITDA forecast 2025. The average Harrow Health, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
10 Harrow Health, Inc. Analysts have issued a net profit forecast 2025. The average Harrow Health, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.49 | 0.43 |
| 34.67% | 187.76% | |
| P/E | 88.57 | |
| EV/Sales | 5.47 |
10 Analysts have issued a Harrow Health, Inc. forecast for earnings per share. The average Harrow Health, Inc. EPS is
This results in the following potential growth metrics and future valuations:
Harrow Health, Inc....
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Ladenburg Thalmann |
Locked
➜
Locked
|
Locked | Nov 12 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Nov 12 2025 |
| B. Riley Securities |
Locked
➜
Locked
|
Locked | Oct 01 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Sep 29 2025 |
| Lake Street |
Locked
➜
Locked
|
Locked | Sep 29 2025 |
| BTIG |
Locked
➜
Locked
|
Locked | Sep 29 2025 |
| BTIG |
Locked
➜
Locked
|
Locked | Sep 24 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Ladenburg Thalmann:
Locked
➜
Locked
|
Nov 12 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Nov 12 2025 |
|
Locked
B. Riley Securities:
Locked
➜
Locked
|
Oct 01 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Sep 29 2025 |
|
Locked
Lake Street:
Locked
➜
Locked
|
Sep 29 2025 |
|
Locked
BTIG:
Locked
➜
Locked
|
Sep 29 2025 |
|
Locked
BTIG:
Locked
➜
Locked
|
Sep 24 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


